Abstract

Prognostic models for disease occurrence, tumor progression and survival are abundant for most types of cancers. Physicians and cancer patients are utilizing these models to make informed treatment decisions and corresponding arrangements. However, not all cancer prognostic models are built and validated rigorously. Some are more useful and reliable than others. In this chapter, we briefly introduce some popular machine learning methods for constructing cancer prognostic models, and discuss pros and cons of each. We also introduce the commonly used discrimination and calibration metrics for assessing predictive performance and validating the prognostic models. In the end, we outline several challenges of using prognostic models in the real world for clinical decision-making support, and propose related suggestions.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.